News & Events

Learn about what's new with CMC Biologics

AGC Biologics Increases Footprint in Bothell, WA

News

Addition of new facilities supports strong company-wide growth initiative

BOTHELL, Wash. –  March 29, 2018 -- AGC Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, announced today the addition of a new building complex that will house the company’s global headquarters in Bothell, Washington.

AGC Biologics Appoints Two New Sr. Vice Presidents of Business Development

News

Axel Schleyer, Ph.D. named Senior Vice President of Business Development, North America
Christoph Winterhalter, Ph.D. named Senior Vice President of Business Development, Europe

BOTHELL, Wash. –  March 13, 2018 -- AGC Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, announced today the appointment of Axel Schleyer as Senior Vice President of Business Development, North America, and Christoph Winterhalter as Senior Vice President of Business Development, Europe. Mr. Schleyer and Mr. Winterhalter will report to Robert Broeze, Chief Business Officer.

AGC Biologics Expands Capacity at Berkeley, California Facility

News

BERKELEY, Calif., March 6, 2018 /PRNewswire/ -- AGC Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, announced today that their Berkeley, California facility is adding to its growing capacity with the addition of a 2000L single-use bioreactor (SUB).

Follow Us
Join us on LinkedIn Follow us on Twitter